The Wistar Institute launches new research center of melanoma

Melanoma Biomarkers -: The Center also seeks to determine the biological imprint called biomarkers that physicians can use to classify specific types of melanoma tumors by blood test or biopsy. These biomarkers will allow physicians to better diagnose patients and their card during the treatment.The Wistar Institute is an international leader in biomedical research, with particular expertise in cancer research and development of vaccines. Founded in 1892 as the first independent research institute, non-profit biomedical research in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible.

Inhaled insulin also proved effective in reducing blood sugar levels as an injection of insulin standard of care, and with minimal side effects in patients with uncontrolled type 2 diabetes, according to a new study.

In addition to providing a basis for melanoma new science, Wistar Institute Melanoma Research Center is the hub of activity that links scientists and physicians from universities, independent research institutes, medical centers and pharmaceutical companies across the nation and the world. Their combined efforts, motivated and supported by the community Melanoma defense, bring on the testing of new drugs and new hope for melanoma patients and their families, Herlyn says.

In addition to the genetics of cancer, a research program of the Center include:

– Biological bases for the prevention of melanoma: Even though Americans tend to spend less time in the sun today as the latest generations of our ancestors, who are more likely to suffer the effects of ultraviolet light, which can account for rates growth of melanoma. If properly designed, the molecular changes in cells of the skin at the base of this phenomenon may one day be applied to the prevention of melanoma.

Melanoma has reached a crisis point in this country and around the world.S. last year alone, according to the American Cancer Society. Unlike many, the incidence of melanoma is increasing, doubling in the last 30 years in the U.S., despite a better understanding and greater awareness of the dangers of sun exposure to ultraviolet light. There are effective treatments for advanced melanoma.

In an attempt to meet the growth front, the Wistar Institute announced the establishment of the Wistar Institute Melanoma Research. The Centre brings together scientists, physicians, the life sciences industry and save lives of melanoma advancing new and better therapies for this deadly disease.

Paths Melanoma -: all cells, cancerous or not, the function through complex networks, in which genes and proteins related to each other, either by direct contact or chemical signals. These channels can be a driving factor, or the arrest of melanoma. The researchers suggest that combination therapies, when involving multiple genes at a time, perhaps the best way to prevent drug resistance in melanoma.

Sc., Professor and Director of Molecular and Cellular Oncogenesis Program Wistar.

With this center, we aim to give a complete look on the nature of melanoma and plan exactly what steps we must take to develop new methods of detection, prevention and therapy.